MCID: ESP005
MIFTS: 15

Esophagus Carcinoma in Situ

Categories: Cancer diseases, Gastrointestinal diseases

Aliases & Classifications for Esophagus Carcinoma in Situ

MalaCards integrated aliases for Esophagus Carcinoma in Situ:

Name: Esophagus Carcinoma in Situ 12 15
Carcinoma in Situ of Esophagus 12 74
Stage 0 Carcinoma of the Esophagus 12
Severe Esophageal Dysplasia 12

Classifications:



External Ids:

Disease Ontology 12 DOID:9095
ICD9CM 36 230.1
SNOMED-CT 69 92585006
ICD10 34 D00.1
UMLS 74 C0154059

Summaries for Esophagus Carcinoma in Situ

Disease Ontology : 12 An in situ carcinoma that is located in the esophagus.

MalaCards based summary : Esophagus Carcinoma in Situ, is also known as carcinoma in situ of esophagus. An important gene associated with Esophagus Carcinoma in Situ is ODC1 (Ornithine Decarboxylase 1). The drugs Fentanyl and Pancreatic Polypeptide have been mentioned in the context of this disorder. Affiliated tissues include the esophagus.

Related Diseases for Esophagus Carcinoma in Situ

Comorbidity relations with Esophagus Carcinoma in Situ via Phenotypic Disease Network (PDN):


Esophageal Disease

Symptoms & Phenotypes for Esophagus Carcinoma in Situ

Drugs & Therapeutics for Esophagus Carcinoma in Situ

Drugs for Esophagus Carcinoma in Situ (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 28)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
2 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
3 Cola Phase 3
4 Central Nervous System Depressants Phase 3
5 Peripheral Nervous System Agents Phase 3
6 Analgesics, Opioid Phase 3
7 Anesthetics Phase 3
8 Anesthetics, Intravenous Phase 3
9 Narcotics Phase 3
10 Adjuvants, Anesthesia Phase 3
11 Analgesics Phase 3
12 Liver Extracts Phase 3
13 Anesthetics, General Phase 3
14
Trioxsalen Approved Phase 2 3902-71-4 5585
15
Fluorouracil Approved Phase 2 51-21-8 3385
16
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
17
Cisplatin Approved Phase 2 15663-27-1 441203 84093 2767
18 Dermatologic Agents Phase 2
19 Photosensitizing Agents Phase 2
20 Dihematoporphyrin Ether Phase 2
21 Ether Phase 2
22 Immunosuppressive Agents Phase 2
23 Antimetabolites Phase 2
24 Antineoplastic Agents, Phytogenic Phase 2
25 Albumin-Bound Paclitaxel Phase 2
26 Antimitotic Agents Phase 2
27 Antimetabolites, Antineoplastic Phase 2
28 Immunologic Factors Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
2 Photodynamic Therapy in Treating Patients With Early Esophageal Cancer Completed NCT00002935 Phase 2 porfimer sodium
3 Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer Completed NCT00281736 Phase 2 HPPH
4 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer Completed NCT00021320 Phase 2 cisplatin;fluorouracil;paclitaxel
5 Genetic and Environmental Risk Factors Related to Esophageal Cancer Recruiting NCT01035398

Search NIH Clinical Center for Esophagus Carcinoma in Situ

Genetic Tests for Esophagus Carcinoma in Situ

Anatomical Context for Esophagus Carcinoma in Situ

The Foundational Model of Anatomy Ontology organs/tissues related to Esophagus Carcinoma in Situ:

20
The Esophagus

Publications for Esophagus Carcinoma in Situ

Variations for Esophagus Carcinoma in Situ

Expression for Esophagus Carcinoma in Situ

Search GEO for disease gene expression data for Esophagus Carcinoma in Situ.

Pathways for Esophagus Carcinoma in Situ

GO Terms for Esophagus Carcinoma in Situ

Sources for Esophagus Carcinoma in Situ

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....